Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Hauer

Showing results (1-10 of 183) with videos related to

Pageof 19
Sort By:
Digestive Diseases and Sciences|March 5, 2014
Toward development of interleukin-11 as a medical countermeasure for use in radiological/nuclear emergenciesMartin Hauer-Jensen
Radiation Research|August 23, 2013
Luis Felipe Fajardo L-G, MD, 1927-2013Martin Hauer-Jensen
Current Opinion in Supportive and Palliative Care|January 10, 2012
Novel drugs to ameliorate gastrointestinal normal tissue radiation toxicity in clinical practice: what is emerging from the laboratory?Maaike Berbée, Martin Hauer-Jensen
Research & Reviews. Journal of Pharmacy and Pharmaceutical Sciences|January 19, 2016
Particle Beam may have Higher Effectiveness in Treating Chemo-resistant Cancers than Low-LET Photon Beam TherapyRupak Pathak, Martin Hauer-Jensen
Antioxidants & Redox Signaling|December 21, 2013
Ionizing radiation-induced responses: where free radical chemistry meets redox biology and medicineDouglas R Spitz, Martin Hauer-Jensen
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2002
The radiotherapeutic injury--a complex 'wound'James W Denham, Martin Hauer-Jensen
Current Drug Targets|June 30, 2010
Targets of potential radioprotective drugsMartin Hauer-Jensen, K Sree Kumar
Radiation Research|February 19, 2016
James William Osborne, PhD 1928-2015Douglas R Spitz, Martin Hauer-Jensen
International Journal of Molecular Sciences|May 7, 2016
γ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current StatusVijay K Singh, Martin Hauer-Jensen
Lancet (London, England)|September 27, 2013
Radiation induced bowel injury: a neglected problemJames W Denham, Martin Hauer-Jensen
Pageof 19

Showing results (1-10 of 183) with videos related to

Sort By:
Pageof 19
Digestive Diseases and Sciences|March 5, 2014
Toward development of interleukin-11 as a medical countermeasure for use in radiological/nuclear emergenciesMartin Hauer-Jensen
Radiation Research|August 23, 2013
Luis Felipe Fajardo L-G, MD, 1927-2013Martin Hauer-Jensen
Current Opinion in Supportive and Palliative Care|January 10, 2012
Novel drugs to ameliorate gastrointestinal normal tissue radiation toxicity in clinical practice: what is emerging from the laboratory?Maaike Berbée, Martin Hauer-Jensen
Research & Reviews. Journal of Pharmacy and Pharmaceutical Sciences|January 19, 2016
Particle Beam may have Higher Effectiveness in Treating Chemo-resistant Cancers than Low-LET Photon Beam TherapyRupak Pathak, Martin Hauer-Jensen
Antioxidants & Redox Signaling|December 21, 2013
Ionizing radiation-induced responses: where free radical chemistry meets redox biology and medicineDouglas R Spitz, Martin Hauer-Jensen
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2002
The radiotherapeutic injury--a complex 'wound'James W Denham, Martin Hauer-Jensen
Current Drug Targets|June 30, 2010
Targets of potential radioprotective drugsMartin Hauer-Jensen, K Sree Kumar
Radiation Research|February 19, 2016
James William Osborne, PhD 1928-2015Douglas R Spitz, Martin Hauer-Jensen
International Journal of Molecular Sciences|May 7, 2016
γ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current StatusVijay K Singh, Martin Hauer-Jensen
Lancet (London, England)|September 27, 2013
Radiation induced bowel injury: a neglected problemJames W Denham, Martin Hauer-Jensen
Pageof 19